Union minister of state for road transport and highways, shipping and chemicals & fertilizers, SHRI MANSUKH LAL MANDAVIYA, today in Rajya Sabha , informed that during the monitoring of compliance with various provisions of Drugs (Prices Control) Order, 2013 (DPCO, 2013) by drug manufacturers, it is seen that the provisions related to ‘new drugs’ have not been followed in some cases wherein pharmaceutical companies have launched the formulation without taking prior price approval from NATIONAL PHARMACEUTICAL PRICING AUTHORITY (NPPA). The concerned companies were instructed to furnish certified batch wise production and sales details along with the corresponding MRP for the formulations from the date of launch of the product till date. Demand notices for an amount of Rs. 74.65 crore have been issued to the erring pharmaceutical companies for launching such drugs/medicines without prior price approval of NPPA. Out of this, AN AMOUNT OF RS. 1.05 CRORE HAS SO FAR BEEN RECOVERED ...
Compliance Chambers is a research-based Indian law firm with offices in Delhi and Rajasthan and aims at providing strategic, legal and tax services across various sectors. The firm represents a myriad of client base, including business houses, MNCs, Financial Institutions, and Non-Governmental Organisations.The firm specializes in certain specific sectors, including Manufacturing, Healthcare, Food and Drug, Cosmetics, Outsourcing, Retail & Wholesale Trade and Real Estate Laws.